Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2013
07/11/2013US20130178445 Novel Benzopyran Compounds, Compositions and Uses Thereof
07/11/2013US20130178443 Phenylquinazoline derivatives
07/11/2013US20130177529 Pyrazole Compounds
07/10/2013EP2612858A1 STAT3/5 activation inhibitor
07/10/2013EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
07/10/2013EP2612854A1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors
07/10/2013EP2612852A1 Theramutein modulators
07/10/2013EP2611793A1 2-cycloquinazoline derivatives and methods of use thereof
07/10/2013EP2611789A1 Quinazoline compounds and methods of use thereof
07/10/2013EP2611786A1 New compositions and methods for controlling nematode pests
07/10/2013EP2611502A1 Adenosine a3 receptor modulating compounds and methods of use thereof
07/10/2013EP2611448A1 7-cyclylquinazoline derivatives and methods of use thereof
07/10/2013EP2611300A1 Substituted fused pyrimidinones and dihydropyrimidinones
07/10/2013CN203043997U Novel continuous cyclization equipment of TGIC (triglycidyl isocyanurate)
07/10/2013CN203043954U Novel continuous cyclization feeding kettle of TGIC (triglycidyl isocyanurate)
07/10/2013CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof
07/10/2013CN103201273A Novel compounds for organic electronic material and organic electroluminescent device using the same
07/10/2013CN103201267A Ampk-activating heterocyclic compounds and methods for using the same
07/10/2013CN103193722A Novel quinazoline nitrogen mustard compound, and preparation method and application thereof to treatment of cancer
07/10/2013CN103193697A Light-emitting device material and light-emitting device
07/10/2013CN102079744B Deuterated achiral crizotinib and derivatives, preparation method and application thereof
07/10/2013CN101687841B Benzimidazole derivatives
07/10/2013CN101638383B Quinoline as well as pharmaceutical composition and use thereof
07/10/2013CN101253166B Sulfonamide compound
07/09/2013US8481715 Methods for isolating crystalline form I of 5-azacytidine
07/09/2013US8481714 Light-responsive artificial nucleotide having photo-crosslinking ability
07/09/2013US8481539 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
07/09/2013US8481534 5- and 6-membered heterocyclic compounds
07/09/2013CA2761440C Fredericamycin derivatives
07/09/2013CA2671749C Bicyclic compounds and uses as antidiabetics
07/09/2013CA2580610C Diaminotriazole compounds useful as protein kinase inhibitors
07/09/2013CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
07/09/2013CA2520323C Tie-2 modulators and methods of use
07/09/2013CA2516407C Heteroarylcarbamoylbenzene derivatives
07/09/2013CA2408408C Modulators of tnf- alpha signaling
07/04/2013WO2013102111A1 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine- carbaldehydes, and methods of formation and use
07/04/2013WO2013098375A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders
07/04/2013WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators
07/04/2013WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors
07/04/2013US20130172557 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine- carbaldehydes, and methods of formation and use
07/04/2013US20130172525 Method for producing epoxy compound having cyanuric acid skeleton
07/04/2013US20130172522 Epoxy compound with nitrogen-containing ring
07/04/2013US20130172390 Haloalkyl-Substituted Amides as Insecticides and Acaricides
07/04/2013US20130172384 Fatty acid synthase inhibitors
07/04/2013US20130172354 Heteroaryl compounds and their uses
07/04/2013US20130172352 5-membered heterocycle-based p38 kinase inhibitors
07/04/2013US20130172351 Dihydropyrazoles
07/04/2013US20130172348 Novel and selective ccr2 antagonists
07/04/2013US20130172347 C5ar antagonists
07/04/2013US20130172341 Fused pyrazole derivatives as novel erk inhibitors
07/04/2013US20130172339 Sulfonamide compounds
07/04/2013US20130172334 Trpv1 antagonists
07/04/2013US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c
07/04/2013US20130172317 Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
07/04/2013US20130172316 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013US20130172315 Substituted anilines as ccr(4) antagonists
07/04/2013US20130172312 Azetidine Derivatives
07/04/2013CA2861202A1 Novel nicotinamide derivative or salt thereof
07/04/2013CA2861013A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors
07/03/2013EP2609088A1 5-iodo-triazole derivatives
07/03/2013EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
07/03/2013CN103189370A Triazole derivatives as ligands for GABA receptors
07/03/2013CN103189367A Chromene derivatives
07/03/2013CN103183668A Derivative of natural product Mansonone E and preparation and application thereof
07/03/2013CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent
07/03/2013CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator
07/03/2013CN103183627A 1,2-diaryl-5-substituted-1H-pyrrole compounds, and preparation method and application thereof
07/03/2013CN101952259B Benzodiazepine compound and pharmaceutical composition
07/02/2013US8476449 Radioactive iodine labeled organic compound or salt thereof
07/02/2013US8476434 Protein kinase modulators and method of use
07/02/2013US8476432 Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof
07/02/2013US8476295 Bridged bicyclic RHO kinase inhibitor compounds, composition and use
07/02/2013US8476286 Quinazoline derivatives which promote the release of parathyroid hormone
07/02/2013US8476276 Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use
07/02/2013US8476274 Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
07/02/2013CA2737694C Novel cyclic benzimidazole derivatives useful anti-diabetic agents
07/02/2013CA2464094C Methods for ligand discovery
06/2013
06/27/2013WO2013096226A1 Trpv1 antagonists
06/27/2013WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013095304A1 Processes for preparing indoles
06/27/2013WO2013094676A1 Hydroxymethylfurfural derivative
06/27/2013WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
06/27/2013WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/27/2013WO2013092893A1 Chemical compounds
06/27/2013WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors
06/27/2013WO2013092500A1 Substituted 4-cyan-3-phenyl-4-(pyridine-3-yl)butanoates, processes for preparation thereof and use thereof as herbicides and plant growth regulators.
06/27/2013WO2013092430A1 Strigolactam derivatives as plant growth regulating compounds
06/27/2013WO2013061205A3 (4 - phenylimidazol - 2 - yl) ethylamine derivatives usful as sodium channel modulators
06/27/2013US20130165489 Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
06/27/2013US20130165460 Sulfur derivatives as chemokine receptor modulators
06/27/2013US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
06/27/2013US20130165442 Modulators of ATP-Binding Cassette Transporters
06/27/2013US20130165423 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
06/27/2013US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
06/27/2013US20130164259 1,4-substituted piperazine derivatives and methods of use thereof
06/27/2013US20130164218 Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents
06/27/2013CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 694